From the perspective of timing, the global respiratory market is growing rapidly because of pollution, increasing cases of respiratory diseases, and awareness of health. Illnesses such as asthma, chronic obstructive pulmonary disease (COPD), bronchitis, and seasonal allergies are creating significant demand for respiratory medicines and treatments. Investing in a respiratory PCD pharma company today has […]